Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,089 public trials 1,370 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Thyroid Cancer and Sunitinib

NCT00510640

Conditions
Cancer, Endocrine Gland Neoplasms, Endocrine System Diseases, +6 more
Locations
  • Centre Paul Papin - 2 rue Moll Angers, France
  • Département Endocrinolo-Diabéto-Nutrition - CHU d'Angers - 4 rue de Larray Angers, France
  • Service d'Oncologie Médicale et de Radiothérapie - Hôpital Saint André - 1 rue Jean Burguet Bordeaux, France
  • Fédération Endocrinologie - Groupe Hospitalier Est - Hôpital neurologique - CHU Lyon - 59 Boulevard Pinel Bron, France
View all 15 locations
View Trial Details
Completed

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

NCT06119217

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Investigative Site Tucson, Arizona, United States
  • Investigative SIte Hot Springs, Arkansas, United States
  • Investigative Site Bakersfield, California, United States
  • Investigative Site Fullerton, California, United States
View all 64 locations
View Trial Details
Completed

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

NCT04214210

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations
  • HFR Fribourg - Hôpital cantonal Fribourg, Canton of Fribourg, Switzerland
  • Hirslanden Clinic Des Grangettes Geneva, Canton of Geneva, Switzerland
  • Hopital du Jura - Service d' Oncology Delémont, Canton of Jura, Switzerland
  • Kantonalspital Winterthur Winterthur, Canton of Zurich, Switzerland
View Trial Details
Completed

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

NCT04295577

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Royal United Hospitals Bath Bath, United Kingdom
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
View all 15 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details

Related conditions